Prospective molecular biological and serological examination for the detection of SARS-CoV-2 (COVID-19) in employees of a hospital of regular care in Germany

Prospective molecular biological and serological examination for the detection of SARS-CoV-2 (COVID-19) in employees of a hospital of regular care in Germany - ProCoV

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00021270

Enrollment

900

Registered

2020-04-15

Start date

2020-04-14

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

U07.1

Interventions

Group 1: All employees at Reinbek Hospital are smeared weekly on COVID-19 and a blood sample is taken for the antibody test. At the same time, a daily online survey of the state of health takes place.

Eligibility

Sex/Gender

All

Age

16 Years to No maximum

Inclusion criteria

Inclusion criteria: Actually working in the study center

Exclusion criteria

Exclusion criteria: No informed consent

Design outcomes

Primary

Measure	Time frame
How many employees develop a COVID-19 positive test and how many develop antibodies in the sense of a seroconversion?	—

Secondary

Measure	Time frame
Correlation between symptoms and positive test results Do certain groups show certain symptoms and certain courses?	—

Countries

Germany

Contacts

Public ContactJonas Herzberg

Krankenhaus Reinbek St. Adolf-Stift

jonas.herzberg@krankenhaus-reinbek.de00494072803300

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026